Biosynthetic butadiene
- Research
- Lab
- Pilot
- Scale-up
- Commercial
- Mature
01Overview and value chain
Markers: [EC: REACH chemical registration (EC 1907/2006) | OECD: Industrial biotechnology | Regulator: REACH (EU), EPA (US)]
Roughly 15 million tons of 1,3-butadiene are produced globally each year, almost entirely from fossil naphtha cracking, to supply synthetic rubber (for tires) and ABS plastics. Axens, Michelin and IFPEN’s BioButterfly technology converts bioethanol into butadiene through a two-reactor catalytic process — ethanol is first dehydrogenated to acetaldehyde, which then reacts with further ethanol to form butadiene — and has been running at an industrial demonstration plant at a Michelin site for three years, producing tires with the resulting bio-based butadiene; Michelin and Axens announced discussions in July 2026 to accelerate deployment of the technology. ETB Global, based in the Netherlands, holds a patented single-reactor process that converts bioethanol directly into butadiene, building on a prior collaboration with Trinseo to explore purified bio-based 1,3-butadiene for green-tyre rubber. A separate chemistry route emerged in April 2026, when BioVerde Tech (Houston, Texas) and Unibio (Roskilde, Denmark) announced a strategic partnership combining BioVerde’s engineered methanotroph strains with Unibio’s commercial-scale U-Loop gas fermentation reactors to convert methane directly into butadiene and related chemical intermediates, an initial target application for a platform Unibio otherwise operates for single-cell protein. No Chinese or Indian company cleared source confirmation as a dedicated bio-butadiene commercial originator as of 2026.
The key directions of biosynthetic butadiene are:
- Catalytic bioethanol-to-butadiene conversion (Ethanol-to-Butadiene Catalysis): two-step dehydrogenation/condensation chemistry converting bioethanol into butadiene at demonstration scale — Axens/Michelin/IFPEN’s BioButterfly.
- Methane gas fermentation to butadiene (Methane Gas Fermentation to Butadiene): engineered methanotroph strains grown in commercial-scale gas fermentation reactors convert methane directly into butadiene and other chemical intermediates — the BioVerde Tech/Unibio partnership.
- One-step bioethanol-to-butadiene synthesis (One-Step Butadiene Synthesis): a single-reactor catalytic route converting bioethanol directly into butadiene, a simpler alternative to the two-reactor BioButterfly process — ETB Global.
- Demonstration-to-commercial scale-up (Bio-Butadiene Scale-Up): moving bio-butadiene routes from tonnes-per-year demonstration plants toward the volumes required to supply tire and plastics manufacturers — the common bottleneck across all three companies.
Sectoral value chain
[bioethanol/methane feedstock] ──> [catalytic conversion or gas fermentation] ──> [butadiene purification]
│
(co-products: bio-hydrogen, ethylene)
│
▼
[commercial-scale plant] <─── [tire/rubber/ABS manufacturing] <─────┘Value chain levels
| Level | Description | Key inputs/outputs |
|---|---|---|
| Feedstock Sourcing | sourcing bioethanol (from sugar/starch fermentation) or methane (natural gas, biogas) as the carbon feedstock | In: bioethanol or methane supply. Out: feedstock-ready input stream. |
| Catalytic Conversion / Gas Fermentation | bioethanol is catalytically dehydrogenated and condensed, or methane is fermented by engineered methanotrophs, into crude butadiene | In: bioethanol/methane, catalyst or microbial strain. Out: crude butadiene stream. |
| Purification | crude butadiene is purified to the specification required for synthetic-rubber and ABS polymerization | In: crude butadiene. Out: polymer-grade 1,3-butadiene. |
| Co-Product Recovery | recovery of co-products generated alongside butadiene, such as bio-hydrogen and ethylene | In: conversion off-gas/byproduct stream. Out: marketable co-products. |
| Demonstration/Pilot Operation | operating a demonstration or pilot plant to validate process economics and product quality at meaningful scale | In: polymer-grade butadiene, plant operating data. Out: validated process ready for scale-up. |
| Commercial Scale-Up | expanding from demonstration scale to volumes sufficient for tire, rubber and plastics manufacturers | In: validated process, customer offtake interest. Out: commercial-scale bio-butadiene supply. |
Cross-cutting technologies of the sector:
- Two-step dehydrogenation/condensation catalysis (Ethanol-to-Butadiene Catalysis): the BioButterfly chemistry converting bioethanol to acetaldehyde in a first reactor, then condensing it with further ethanol into butadiene in a second reactor.
- Engineered methanotroph gas fermentation (Methane Gas Fermentation to Butadiene): microbial strains engineered to convert methane into multi-carbon chemical intermediates, run in commercial-scale gas fermentation reactors (Unibio’s U-Loop design).
- Single-reactor catalytic conversion (One-Step Butadiene Synthesis): ETB Global’s patented process condensing the two-step BioButterfly chemistry into a single catalytic reactor.
02US
The US hosts the methane-fermentation route to bio-butadiene, in an early-stage partnership announced in 2026.
BioVerde Tech, EPA
- BioVerde Tech (Houston, Texas): develops engineered methanotroph strains that convert methane into chemical intermediates and protein-rich biomass, holding multiple granted and pending US patents on methane-to-multi-carbon-compound biological conversion; in April 2026 it announced a strategic partnership with Denmark’s Unibio targeting butadiene as an initial chemical application of the combined platform.
- EPA framework: bio-based butadiene produced from methane or bioethanol feedstocks in the US falls under standard EPA industrial-chemical and, where renewable-fuel-linked feedstocks are involved, Renewable Fuel Standard frameworks, alongside conventional TSCA chemical review.
03CN
No Chinese company cleared source confirmation as a dedicated bio-butadiene commercial originator as of 2026; the two leading Chinese candidates queried (Cathay Biotech, a major synthetic-biology chemicals producer, and Sinopec, the state petrochemical major) returned no company-specific bio-butadiene product or project coverage — Cathay Biotech’s confirmed 2026 news centers on an unrelated biopharmaceutical subsidiary, and Sinopec’s confirmed activity centers on conventional petrochemical ethylene output.
research gap, NDRC/MIIT petrochemical policy
- Research gap: Chinese industrial-biotechnology reporting in this period emphasizes fermentation-derived platform chemicals broadly (lactic acid, 1,3-propanediol) rather than a dedicated bio-butadiene originator; conventional naphtha- and ethanol-dehydration-based butadiene production remains the confirmed domestic pathway.
- Regulatory pathway: to the extent a bio-butadiene product reached the Chinese market, industrial chemical registration would run through standard MIIT/NDRC petrochemical-sector channels rather than a dedicated biotech pathway.
04EU
Europe hosts both the most advanced bio-butadiene demonstration plant and a competing single-reactor process, anchored in France and the Netherlands.
Axens, ETB Global, REACH
- Axens (Rueil-Malmaison, France): together with Michelin and IFP Energies Nouvelles (IFPEN), operates the BioButterfly bioethanol-to-butadiene technology at an industrial demonstration plant at a Michelin site, running for three years and already used to manufacture tires with bio-based butadiene; Michelin and Axens announced discussions in July 2026 to accelerate the technology’s deployment.
- ETB Global (Netherlands): holds a patented single-reactor process converting bioethanol directly into butadiene, positioned as a drop-in alternative to fossil-derived material, building on a 2021 collaboration with Trinseo exploring purified bio-based 1,3-butadiene for green-tyre synthetic rubber.
- REACH framework: bio-based butadiene manufactured or placed on the EU market falls under REACH chemical registration, evaluation and authorisation, the same regime governing its fossil-derived counterpart.
05Leading companies and research institutes
| Company / Institute | Country | Key products / platforms | Tech features | Status 2026 |
|---|---|---|---|---|
| Axens | 🇫🇷 France | BioButterfly bioethanol-to-butadiene (with Michelin, IFPEN) | Two-reactor dehydrogenation/condensation, 3-year industrial demo plant | commercial |
| ETB Global | 🇳🇱 Netherlands | Patented single-reactor bio-butadiene process | One-step bioethanol-to-butadiene conversion | pilot |
| Unibio | 🇩🇰 Denmark | U-Loop gas fermentation (methane-to-butadiene, with BioVerde) | Commercial-scale gas fermentation reactor design | commercial |
| BioVerde Tech | 🇺🇸 USA | Engineered methanotroph platform | Methane-to-multi-carbon-compound biological conversion, granted US patents | pilot |
06Tech stack and innovations
The stack spans two distinct feedstock-to-butadiene chemistries: catalytic conversion of bioethanol, and biological gas fermentation of methane.
- Two-step catalytic conversion (Ethanol-to-Butadiene Catalysis):
- Axens/Michelin/IFPEN’s BioButterfly dehydrogenates bioethanol to acetaldehyde in a first reactor, then condenses it with further ethanol into butadiene in a second reactor, validated over three years of demonstration-plant operation including production of finished tires.
- Engineered methanotroph gas fermentation (Methane Gas Fermentation to Butadiene):
- BioVerde Tech’s engineered Methylococcus capsulatus strains, deployed within Unibio’s proprietary U-Loop vertical gas fermentation reactors, are designed to convert methane and other low-cost gaseous feedstocks into butadiene and related chemical intermediates.
- Single-reactor catalytic synthesis (One-Step Butadiene Synthesis):
- ETB Global’s patented process condenses bioethanol-to-butadiene conversion into a single catalytic reactor, a simpler alternative to the two-reactor BioButterfly chemistry, building on a prior Trinseo collaboration targeting green-tyre synthetic rubber.
- Demonstration-to-commercial scale-up (Bio-Butadiene Scale-Up):
- Across all three companies, the shared technical challenge is scaling from tonnes-per-year demonstration or pilot operation to the volumes required by tire and plastics manufacturers, a gap Michelin and Axens explicitly targeted in their July 2026 deployment discussions.
07Value chains and production pipelines
Industrial pipeline of biosynthetic butadiene (REACH / EPA)
┌───────────────────────────┐ ┌───────────────────────────┐
│ 1. Feedstock sourcing │ ───> │ 2. Catalytic conversion / │
│ │ │ gas fermentation │
└───────────────────────────┘ └───────────────────────────┘
│
▼
┌───────────────────────────┐ ┌───────────────────────────┐
│ 4. Co-product recovery │ <─── │ 3. Purification │
└───────────────────────────┘ └───────────────────────────┘
│
▼
┌───────────────────────────┐ ┌───────────────────────────┐
│ 5. Demonstration/pilot │ ───> │ 6. Commercial scale-up │
│ operation │ │ │
└───────────────────────────┘ └───────────────────────────┘Stage 1: Feedstock sourcing
Bioethanol (from sugar/starch fermentation) or methane (natural gas, biogas) is sourced as the carbon feedstock, as with Axens/ETB Global’s ethanol route and BioVerde/Unibio’s methane route.
Stage 2: Catalytic conversion / gas fermentation
Bioethanol is catalytically dehydrogenated and condensed into butadiene (BioButterfly’s two-reactor process, ETB Global’s single-reactor process), or methane is fermented by engineered methanotrophs within a gas fermentation reactor (BioVerde/Unibio).
Stage 3: Purification
Crude butadiene is purified to the specification required for synthetic-rubber and ABS polymerization, the step validated at Axens/Michelin’s demonstration plant over three years of operation.
Stage 4: Co-product recovery
Industry coverage of the ethanol route has noted potential co-products including bio-hydrogen and ethylene, which could add value across the wider chemicals chain alongside the primary butadiene stream.
Stage 5: Demonstration/pilot operation
Axens/Michelin/IFPEN’s BioButterfly has operated at industrial demonstration scale for three years, already producing finished tires; the BioVerde/Unibio methane route and ETB Global’s single-reactor process remain at an earlier pilot/partnership stage announced in 2026.
Stage 6: Commercial scale-up
Producers must move from tonnes-per-year demonstration volumes to the scale required by tire and plastics manufacturers; Michelin and Axens’ July 2026 deployment discussions target exactly this step, while supply reliability, certification and cost remain open questions across all three companies.
| Supplier | Price | Lead time | Certificates | Risk | Confidence |
|---|---|---|---|---|---|
| Axens (BioButterfly bioethanol-to-butadiene) | on request (technology license) | custom | 3-year industrial demo plant eu | Medium | HIGH |
| ETB Global (single-reactor bio-butadiene) | on request (process license) | custom | Single-reactor process eu | High | HIGH |
| Unibio (U-Loop gas fermentation) | on request (gas fermentation platform) | custom | Commercial-scale U-Loop reactor eu | High | HIGH |
| BioVerde Tech (engineered methanotroph platform) | on request (methane-to-chemicals platform) | custom | Granted US patents us | High | HIGH |
AI note: biosynthetic-butadiene (EN)
Key directions:
- Ethanol-to-butadiene catalysis — two-reactor dehydrogenation/condensation of bioethanol; Axens/Michelin/IFPEN’s BioButterfly, 3-year industrial demo plant, tires already produced.
- Methane gas fermentation to butadiene — engineered methanotroph strains in commercial-scale gas fermentation reactors; BioVerde Tech + Unibio, partnership announced April 2026.
- One-step butadiene synthesis — single-reactor bioethanol-to-butadiene process; ETB Global, prior 2021 Trinseo collaboration.
- Bio-butadiene scale-up — moving from tonnes/year demo scale to commercial tire/plastics volumes; the shared bottleneck across all three companies, explicitly the subject of Michelin/Axens’ July 2026 deployment discussions.
Regulatory:
- US: EPA industrial-chemical framework, Renewable Fuel Standard where feedstock-linked, TSCA chemical review.
- EU: REACH chemical registration and evaluation (same regime as fossil-derived butadiene).
- CN: no dedicated bio-butadiene originator confirmed; conventional MIIT/NDRC petrochemical-sector registration would apply if a product emerged.
Companies not in table: Michelin (tire manufacturer and BioButterfly demo-plant host/co-developer — not tabled separately since it’s the end-user/co-developer rather than a chemical-technology originator; IFPEN (French national research institute, BioButterfly R&D co-developer alongside Axens — the technology licensing/commercialization role sits with Axens); Trinseo (US specialty-materials company, ETB Global’s 2021 green-tyre-rubber collaboration partner, mentioned in prose as historical context, not a bio-butadiene originator itself). Dropped candidates after enrich.py: Genomatica (US) — its only confirmed 2026 product is bio-BDO (1,4-butanediol), a different molecule, not bio-butadiene — technology mismatch, dropped. LanzaTech (US) — confirmed sources cover general gas-fermentation acetone/isopropanol/carbon-black work, no bio-butadiene-specific confirmation — dropped. Versalis (Italy) and Global Bioenergies (France) — both drafted as EU candidates but their confirmed 2026 activity is bio-isobutene (Global Bioenergies) or generic tire-industry commentary with no company-specific bio-butadiene product (Versalis) — both already tabled with the same generic “Bio-Butadiene” claim in the pre-existing biosynthetic-latex (INT-119) dummy-skeleton article, which is itself unverified filler text, not a real source; dropped here in favor of the two source-confirmed EU originators (Axens, ETB Global). Cathay Biotech and Sinopec (China, 2 attempts, cap reached) — no bio-butadiene-specific confirmation; Cathay Biotech’s confirmed news is an unrelated biopharma subsidiary, Sinopec’s is conventional ethylene output — CN written qualitative. Praj Industries and a generic India query (2 attempts, cap reached) — the one on-topic India hit (Godavari Biorefineries/Synthomer) confirmed bio-based butyl acrylate from bio-butanol, a different molecule — technology mismatch; India omitted from regions entirely (no qualitative section written, following the synthetic-biomarkers precedent of omitting a region with zero relevant hits rather than forcing a paragraph).
Processing note: two genuinely distinct chemistries compete here — bioethanol catalytic conversion (Axens/BioButterfly, ETB Global) vs. methane gas fermentation (BioVerde Tech/Unibio) — both still pre-commercial (demo plant or 2026-announced partnership), which is why risk is “high” and pipeline_stage is 4 despite Axens’ BioButterfly having 3 years of real demo-plant operation and finished tires. Unibio is a pre-existing canonical entity (already tabled in gas-fermentation-food-protein and industrial-single-cell-protein-for-feed for its core single-cell-protein business) — repointed to the existing slug, not duplicated; its butadiene work is a 2026 diversification, not its primary business, so this article’s prose is explicit about that.
Relevance: continues the platform-chemicals cluster (6.1) reopened by IND-231 after IND-222 was skip-logged; unlike IND-222/223/228 (all skipped as thin/mece/duplicate in this same sitting), IND-224 biosynthetic butadiene turned up two well-sourced, multi-year-documented EU technology stories (BioButterfly, ETB Global) plus a brand-new 2026 US/EU gas-fermentation partnership (BioVerde/Unibio) — a 4-firm floor with real substance, not a padded table.